NIAID Funding Opportunities: Chemical Countermeasures Research Program and HIV/AIDS in the Era of COVID-19

National Institute of Allergy and Infectious Diseases sent this bulletin at 06/25/2021 04:08 PM EDT

Funding Opportunities

RFA-ES-21-006, CCRP Initiative—Chemical Threat Agent-Induced Pulmonary and Ocular Pathophysiological Mechanisms (R01, Clinical Trial Not Allowed)
NOT-AI-21-057, Notice of Special Interest (NOSI)—HIV/AIDS in the Era of COVID-19 - When Pandemics Collide

For more, check NIAID Opportunities and Announcements.

You can follow us on Twitter: @NIAIDFunding.

National Institute of Allergy and Infectious Diseases | National Institutes of Health

Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help.

This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).